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'recommended' and 15 (75%) responded that the video was 
'helpful to understand radiation treatment'. After watching 
the video, average set up error at the first verification 
process was significantly decreased compared to the 
historical values of 124 patients (1.6 mm versus 2.2 mm, p = 
0.03). In web, two thousand two hundred people globally 
viewed YouTube videos about radiotherapy. 
 
Conclusion: Implementation of education video instructing 
the radiotherapy process helped to increase patient safety. 
Education based on YouTube could be an effective method 
for cancer patients. 
 
Electronic Poster: Clinical track: Other  
 
 
EP-1463  
Stereotactic body radiation therapy (SBRT). Outcomes and 
toxicities 
A.A. Diaz Gavela
1Hospital Quiron Madrid, Radiation Oncology, Pozuelo de 
Alarcon- Madrid, Spain 
1, E. Del Cerro Peñalver1, F. Marcos 
Jimenez1, F. Couñago Lorenzo1, J. Castro Novais2 
2Hospital Quiron Madrid, Radiophysics, Pozuelo de Alarcon- 
Madrid, Spain 
 
Purpose or Objective: Stereotactic body radiotherapy (SBRT) 
is evolving into a standard of care in cancer management and 
consists in giving high doses of radiation to tumor deposits in 
extracranial locations. The objective of our study is to show 
our results in terms of toxicity and local response after 
implementing the technique in our department. 
 
Material and Methods: Between May 2012 to August 2015, 
120 patients (170 lesions) with body metastases or primaries 
of varying histologies were treated with SBRT. We evaluated 
acute (<3months) and late (>3months) toxicities as well as 
the response of the treated lesions. 26 patients were treated 
with a linac-based 3D conformal SBRT planning and 2 lesions 
with static IMRT. The other 142 lesions received a Volumetric 
Modulated Arc Therapy (VMAT) treatment using RA (Rapid 
Arc), 83 with flattening filter and 59 were treated without 
flattening filter (flattening filter free beam- FFF). 
 
Results: The mean age of patients was 60 years (26-87) and 
the median follow-up was 8 months (1-33). The most common 
histology was non-small cell lung cancer and the most 
frequent localizations of the treated lesions were bone 
(31.7%), lung (both metastases and primary, 22.2%), liver 
(17.1%) and lymph node metastases (14.7%); other 
localizations: 14.3%. Administered dose and fractionation 
varied significantly depending on the size and location of 
each lesion and its anatomic relationship with adjacent 
organs at risk, ranging from one to ten fractions and 8 to 
60Gy. The median volume of the PTV was 42.50cc (0.89-
259.08cc). In relation to the local response, we found 74.7% 
of complete or significant responses, 15.8% of minor 
responses or stability, 2.4% progressions and 7.1% 
pseudoprogressions. Acutely, the most frequent toxicities 
were fatigue and bone flair. There were no grade 4 toxicities 
and we identified only one grade 3 acute asthenia. 
Chronically, the most frequent side effect was bone pain 
(3.3%). 
 
Conclusion: Our series confirms excellent local control with a 
low rate of side effects when treating extracranial 
metastases with SBRT. Longer follow-up is necessary to assess 
whether the local response is maintained over time and to 
identify the factors related to SBRT treatment that may 
influence overall survival. 
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Purpose or Objective: To compare the results of low dose 
protontherapy and photodynamic therapy (PDT) for the 
treatment of circumscribed choroidal haemangiomas (CCH). 
 
Material and Methods: 48 patients (48 eyes) eyes with CCH 
were referred, treated between 1994 and 2014 and followed 
in our clinic. A historical series of 20 patients treated with 
protontherapy since 1994 was compared to 28 patients 
treated with photodynamic therapysince 2006. Tumor and 
functional outcomes were compared. Chi-squared or Fisher’s 
tests were used to establish differences between 
discontinuous variables. Student t-test or the Mann-Whitney 
U test was used to compare continuous variables. The 
Spearman test was utilized for correlations. 
 
Results: Groups were comparable for patient (age, gender) 
and disease (size, baseline complications and visual acuity) 
characteristics but neither macular location (16/20 for 
protontherapy, 9/28 for PDT, p 0.02) nor initial thickness 
(higher in the protontherapy group, p 0.02). Mean follow-up 
was 35 months (48 for protontherapy, 24 for PDT p 
0.001).There was a higher rate of retreatment for relapse 
and complications with PDT than protontherapy (p 0.044 and 
0.006, respectively).There was a non-significantly higher gain 
in visual acuity with protontherapy than PDT. There was a 
mean 67% and 32% thickness decrease with protons and PDT 
(p 0.002). 
 
Conclusion: Considering that protontherapy is more invasive 
due to clip placement and uses ionizing radiations, it cannot 
be advocated as a first hand option. However, initially 
promising results with PDT are challenged by protontherapy 
and the current series suggest that protontherapy should be 
proposed after first failure to PDT. Prospective trials are 
warranted to compare the two options as first treatment. 
 
EP-1465  
Early dupuytren's: superficial radiotherapy offers long-
term resolution without hand surgery 
J.P. Glees
1Cancer Centre London- Parkside Hospital, Radiotherapy 
Department, London, United Kingdom 
1 
 
Purpose or Objective: First independent Audit to show that 
giving superficial radiotherapy (100KV Photons) is effective. 
Majority of cases (94%) did not require subsequent hand 
surgery. 
 
Material and Methods: During the period 2010 to 2015, over 
150 patients were treated by one Radiotherapist using the 
European treatment protocol of 10 treatments given over a 2 
to 3 month period (5 fractions over 1 to 2 weeks followed by 
2-month gap and then, the 5 treatments are repeated. Total 
applied dose of 30Gy). Each patient's disease is photographed 
before and after treatment, the palpable disease having been 
marked on the hands and feet in order to clearly show 
benefit achieved.  
 
Results: Independent Audit of a detailed questionnaire sent 
to patients showed 94% were satisfied with results up to 4 
years post treatment. Satisfaction composed of regression of 
disease in hands and feet and/or no further progression of 
the disease.  
 
Conclusion: Superficial radiotherapy is a highly effective and 
inexpensive treatment of Dupuytren's, provided that patients 
are referred during the early stages of the disease. Patients 
are able to continue normal use of hands (and feet) 
throughout the treatment, so their daily lives are not 
altered. General Practitioners, hand surgeons and affected 
patients should be made aware of the good results achieved 
by radiotherapy, without significant morbidity. 
 
 
 
